journal cover

Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder

Biomarkers in Neuropsychiatry

Jan 17, 2020

Anilkumar PillaiNunzio Pomara

Abstract

Late-life major depression (LLMD) is a risk factor for the development of mild cognitive impairment and dementia, including Alzheimer's disease (AD) and vascular dementia. Immune dysregulation and changes in innate immune responses in particular, have been implicated in the pathophysiol...read more

Mentioned in this Paper

Enzyme-Linked Immunosorbent Assay
Dementia, Vascular
Amyloid beta-protein (1-42)
Mild Cognitive Disorder
Major Depressive Disorder
Neuronal Plasticity
Dementia
Cognition
Immune Response
Mental Depression
2
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Vascular Dementia

Vascular Dementia refers to the decline in thinking ability caused by cerebrovascular diseases. Discover the latest research on aspects underlying vascular dementia here.

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Functional Connectivity Networks

Functional connectivity networks represent specific patterns of synchronous activity and differ between healthy subjects, stages of consciousness and across disease. Discover the latest research on functional connectivity networks here.

Glymphatics

The glymphatic system is a CSF-mediated waste clearance pathway that is formed by astroglial cells. The removal of potentially harmful substances such as amyloid protein is important to prevent toxic levels accumulate in the brain. Discover the latest research on glymphatics here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Innate Immunity: Neurodegeneration

The innate immune system is a first line of defense against infection. Pathological states can occur if there is over activation of the innate immune system, particularly in the. The excessive activation of these cells can lead to inflammation and neurodegenerative diseases. Here is the latest research on innate immunity and neurodegeneration.

Myeloid Cells & Neuroinflammation

Myeloid cells in the CNS are innate immune cells that are essential for brain development and maintenance. Here is the latest research on myeloid cells, including microglia, in neuroinflammation.

Tauopathies

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

Myeloid Cells And Neuroinflammation

Myeloid cells in the CNS are innate immune cells that are essential for brain development and maintenance. Here is the latest research on myeloid cells, including microglia, in neuroinflammation.

Alzheimer's Disease: RNA Regulation

RNA regulation involves several mechanisms that are used by cells to decreases or increase the production of RNA. Issues with RNA regulation are associated with Alzheimer's Disease (AD). Here are the latest discoveries pertaining to RNA regulation and this disease.

Extracellular Space: Brain

The extracellular space (ECS) in brain occupies approximately twenty percent of the brain volume and is dynamic and highly regulated. Here is the latest research on ECS in the brain.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Classical Complement Pathway

The Classical Complement Pathway is activated by antigen-antibody complexes. Activation of this pathway leads to the generation of the membrane attack complex, which kills pathogenic cells. Discover the latest research on the Classical Complement Pathway here.

Alzheimer's Disease: APP

Amyloid precursor protein proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques. Here is the latest research.

Neuronal Plasticity

Neuronal plasticity is the brain’s ability to change its structure and function in response to internal or external factors. Here is the latest research on mechanisms that influence this process.

Depression

Depression, also known as major depressive disorder, is a medical condition associated with negative emotional, behavioural, and cognitive symptoms. Here is the latest research on this mood disorder.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Complex Memory Functions

This feed focuses on complex memory functions, including remote memory, recognition memory, and spatial cognition. Here is the latest research.

Neuronal and Network Dysfunction In Neurodegeneration

This feed focuses on neuronal and network dysfunction in neurodegenerative disorders and the effects of tauopathies on synapses and memory.

Alzheimer's Disease: Early Markers

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

© 2020 Meta ULC. All rights reserved

Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder

Biomarkers in Neuropsychiatry

Jan 17, 2020

Anilkumar PillaiNunzio Pomara

PMID: 31942568

DOI: 10.1016/j.bionps.2019.100007

Abstract

Late-life major depression (LLMD) is a risk factor for the development of mild cognitive impairment and dementia, including Alzheimer's disease (AD) and vascular dementia. Immune dysregulation and changes in innate immune responses in particular, have been implicated in the pathophysiol...read more

Mentioned in this Paper

Enzyme-Linked Immunosorbent Assay
Dementia, Vascular
Amyloid beta-protein (1-42)
Mild Cognitive Disorder
Major Depressive Disorder
Neuronal Plasticity
Dementia
Cognition
Immune Response
Mental Depression
2

Similar Papers Found In These Feeds

Vascular Dementia

Vascular Dementia refers to the decline in thinking ability caused by cerebrovascular diseases. Discover the latest research on aspects underlying vascular dementia here.

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Related Papers

Neurobiology of Aging

Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease

Neurobiology of AgingJuly 11, 2017
Joana B PereiraAlzheimer's Disease Neuroimaging Initiative
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/complement-component-3-levels-in-the/31942568